Bristol Myers Squibb (BMY) Net Income (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Net Income of $3.32 billion in Q2 2026, up 152.6% from $1.31 billion a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Net Income came in at $9.27 billion as of Jun 30, 2026, up 83.1% year-over-year; for FY2025, it came in at $7.06 billion.
- Across earlier years, Net Income came in at -$8.93 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
- The Q2 2026 figure is the highest quarterly Net Income since Q4 2009.
- On a year-over-year basis, Net Income rose in three of the last six quarters, with growth averaging 14.5%.
- Peak year-over-year performance for Net Income in the last five years was growth of 152.6% in Q2 2026, against a decline of 95.7% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.68 billion (Q1 2026), $1.09 billion (Q4 2025) and $2.2 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Bristol Myers Squibb | 125.02 Bn | 76.29 Bn | 9.25 Bn | 3.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 72.00 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.55 Bn |
API Access
Bristol Myers Squibb Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();